Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Moderately to Severely Active Ulcerative Colitis Clinical Trials

3 recruiting trials for Moderately to Severely Active Ulcerative Colitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
3
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT06588855

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in...

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in...

Sponsor: Hoffmann-La RocheEnrolling: 35020 locations
RECRUITINGPhase 3NCT07158242

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to...

This Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and efficacy of Afimkibart (RO7790121) in pediatric participants...

Sponsor: Hoffmann-La RocheEnrolling: 1004 locations
RECRUITINGPhase 3NCT03221036

Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis

The purpose of this study is to assess the effect of vedolizumab intravenous IV as induction and maintenance treatment in Chinese participants with moderately to severely active...

Sponsor: TakedaEnrolling: 40220 locations